Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine-Reference-Cited by-同舟云学术

Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine

Published:2021-08 Issue: Volume:8 Page:100102
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Konz John O.^ORCID,Schofield Tim^ORCID,Carlyle Sarah^ORCID,Wahid Rahnuma^ORCID,Ansari Azeem^ORCID,Strating Jeroen R.P.M.,Yeh Ming Te,Manukyan Hasmik,Smits Saskia L.,Tritama Erman,Rahmah Latri^ORCID,Ugiyadi Dori,Andino Raul,Laassri Majid^ORCID,Chumakov Konstantin,Macadam Andrew^ORCID

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. World Health Organization (WHO). Report from the Twentieith Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis. Geneva; 2019.

2. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden;Platt;J Infect Dis,2014

3. Update on vaccine-derived poliovirus outbreaks — worldwide, July 2019–February 2020;Alleman;MMWR Morb Mortal Wkly Rep,2020

4. GPEI. Circulating vaccine-derived poliovirus n.d. https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/ [accessed February 22, 2021].

5. Sutter RW, Kew OM, Cochi SL, Aylward RB. Poliovirus vaccine--live. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Elsevier; 1993. p. 598–645.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine process technology—A decade of progress;Biotechnology and Bioengineering;2024-05-06

2. Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B;Microbiology Spectrum;2024-04-02

3. High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains;Vaccine;2024-04

4. Novel oral poliovirus vaccine type 2 is an important eradication tool, but reaching every last child remains vital;The Lancet Infectious Diseases;2024-04

5. Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial;The Lancet;2024-03